How metformin extends yeast lifespan through chromatin control and retrotransposon activity

Researchers discovered that metformin extends lifespan in yeast by triggering changes in how genes are packaged (chromatin regulation), which activates retrotransposons—jumping genes that normally increase with age. Surprisingly, metformin increases these genetic elements' activity while …

43 Early
Design 6
Sample 8
Peer Review 14
Replication 5
Transparency 10

Testing Three Anti-Aging Drugs in Older Adults: A Clinical Trial Protocol

This is a protocol paper describing an upcoming clinical trial that will test whether three drugs (metformin, fisetin, and spermidine) can reduce senescent cells and reverse aging hallmarks in healthy adults over 70 within three …

30 Early
Design 6
Sample 7
Peer Review 3
Replication 4
Transparency 10

Some Anti-Aging Compounds Extend Male Worm Lifespan, But Not Always Reproductive Health

Researchers tested seven compounds known to slow aging in hermaphrodite worms on male worms and found that all extended lifespan, but only sulforaphane and metformin improved reproductive function in older males. This suggests that living …

43 Early
Design 6
Sample 8
Peer Review 15
Replication 5
Transparency 9

Metformin TAME Trial Interim Results

Preliminary data shows metformin may delay onset of age-related diseases by 15-20%.

83 Strong
Design 19
Sample 20
Peer Review 18
Replication 8
Transparency 18

Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors in Diabetes Mellitus

Background: GLP1 receptor agonists (GLP1RAs) and SGLT2 inhibitors (SGLT2Is) have established cardiovascular benefits for patients with type 2 diabetes mellitus (T2DM), with similar class-level effectiveness found in previous studies. However, real-world comparative effectiveness assessments of …

34 Early
Design 5
Sample 7
Peer Review 4
Replication 6
Transparency 12

No evidence for squaring the survival curve: lifespan-extending treatments increase variation in age- at-death.

Geroscience has the goal of extending lifespan through geroprotective interventions. These interventions are typically imparted on groups of individuals, with their efficacy judged by increases in the average age-at-death. A more equitable outcome, which looks …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Blood Proteins of Centenarians Reveal Secrets of Extreme Longevity

Researchers analyzed blood proteins from Swiss centenarians and discovered 37 proteins associated with a 'younger' profile that may explain why some people live to 100 and stay healthy. By comparing centenarian patterns across two independent …

56 Promising
Design 11
Sample 8
Peer Review 15
Replication 12
Transparency 10